CambridgeSoft, a provider of e-notebook solutions, entered into an agreement in December 2004 with GlaxoSmithKline (GSK) to provide software licensing to GSK's Global R+D facilities
GSK selected CambridgeSoft's E-Notebook for the flexibility it demonstrated across the wide range of data generated in the many disciplines and functional areas within GSK's Discovery R+D organization.
GSK is partnering with CambridgeSoft to customize the E-Notebook to meet GSK requirements and integrate with key applications and workflow tools.
"CambridgeSoft is pleased to be selected by GSK as their global partner for an E-Notebook for the Discovery R+D organization." said Michael Tomasic, chairman and CEO, CambridgeSoft.
"We welcome GSK to our growing list of top-tier pharmaceutical companies who are working with CambridgeSoft in collaboratively designing and developing solutions to meet their critical data management needs".
CambridgeSoft develops and markets life science enterprise solutions for pharmaceutical, biotechnology, chemical companies and academic research organizations.
Software products include desktop, workgroup and enterprise versions of Chem and Bio Office, including ChemDraw, with knowledge management, chemical and biological informatics, and scientific database solutions.
